NEWNow you possibly can take heed to Fox Information articles!
Florida Gov. Ron DeSantis sued the Biden administration on Wednesday over alleged delays in his state’s makes an attempt to import cheaper prescribed drugs from Canada, saying he hopes Florida residents will not be punished for political variations.
Talking from Lakeland, close to Tampa, the Republican governor spoke of the US Meals and Drug Administration’s overview of an utility for medicine to deal with various illnesses via Canada’s drug import program.
“I might not wish to assume that the Biden administrator wouldn’t approve of this simply because it’s Florida, as a result of they’ve political issues with Florida … as a result of it can profit individuals … no matter political views,” he mentioned.
Florida turned the primary state to use for this system in November 2020, in keeping with Politico. In July 2021, President Biden signed an govt order directing the FDA to implement this system.
FLORIDA GOV. DeSantis Criticizes NEWSOM’S “HORRIBLE MANAGEMENT” IN CALIFORNIA
Simone Marstiller, secretary of the Florida Division of Well being, instructed the FDA in March that Florida had already waited 500 days for its utility to be accepted.
“This has been sitting on somebody’s desk for 600 days,” Marstiller mentioned on Wednesday. “That is not one thing the federal government must be doing.”
Importing low-cost medicine may save Florida residents about $150 million a yr, in keeping with state well being officers.
“You realize, after 630 days, we’re nonetheless sitting right here ready for a solution. And so we predict we have waited lengthy sufficient,” DeSantis mentioned Wednesday. “We now have a proper to know what the FDA has been doing for the previous two years. Do they put politics forward of sufferers? Are they placing the pursuits of Large Pharma forward of the pursuits of bizarre Florida residents?”
CLICK HERE TO GET THE FOX NEWS APP
The Florida lawsuit asks a federal decide to order the FDA to approve the applying, DeSantis mentioned Wednesday. Fox Information has reached out to the FDA for remark.